share_log

蔚蓝生物(603739.SH):全资子公司获得新兽药注册证书

Weilan Biotech (603739.SH): Wholly-owned subsidiary obtains a new veterinary drug registration certificate

Gelonghui Finance ·  Jan 2 02:38

On January 2, Gelonghui Biotech (603739.SH) announced that after review by the Ministry of Agriculture and Rural Affairs, it approved the “Little Goose Fever Freeze-dried Egg Yolk Antibody” jointly declared by Qingdao Weilan Animal Health Group Co., Ltd., a wholly-owned subsidiary of Qingdao Weilan Biology Co., Ltd. and other organizations, as three new types of new veterinary drugs, and recently announced the issuance of the “New Veterinary Drug Registration Certificate”.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment